106 related articles for article (PubMed ID: 6680304)
1. [A mechanism of human complement activation by immunostimulators from the bacterial cell wall].
Kozlov LV; Zinchenko AA; Soliakov LS; Sizoĭ MN; Ishchenko AM
Bioorg Khim; 1983 Aug; 9(8):1047-55. PubMed ID: 6680304
[TBL] [Abstract][Full Text] [Related]
2. [Role of the classical and alternative complement pathways in chemotaxis of human C2 deficiency (author's transl)].
Pham Huu T; Buriot D; Griscelli C
Ann Immunol (Paris); 1980; 131C(1):69-77. PubMed ID: 7396417
[TBL] [Abstract][Full Text] [Related]
3. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
5. [Effect on human complement of blastolysin and the glycopeptide (MDP and GMDP) and carbohydrate fragments of peptidoglycans].
Kozlov LV; Rostovtseva LI; Lomaka TS; Sutovskaia NS; Sorokina IB
Bioorg Khim; 1985 Nov; 11(11):1510-8. PubMed ID: 3853967
[TBL] [Abstract][Full Text] [Related]
6. The C4 and C2 but not C1 components of complement are responsible for the complement activation triggered by the Ra-reactive factor.
Ji YH; Matsushita M; Okada H; Fujita T; Kawakami M
J Immunol; 1988 Dec; 141(12):4271-5. PubMed ID: 3058802
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of immune precipitation by complement.
Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
[TBL] [Abstract][Full Text] [Related]
8. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
Wouters D; Brouwer MC; Daha MR; Hack CE
Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
[TBL] [Abstract][Full Text] [Related]
9. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.
Gyongyossy-Issa MI; McLeod E; Devine DV
J Lab Clin Med; 1994 Jun; 123(6):859-68. PubMed ID: 8201264
[TBL] [Abstract][Full Text] [Related]
10. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation.
Tarr PI; Hosea SW; Brown EJ; Schneerson R; Sutton A; Frank MM
J Immunol; 1982 Apr; 128(4):1772-5. PubMed ID: 6977569
[TBL] [Abstract][Full Text] [Related]
11. [Specific measurement of alternate pathway activation of complement in human glomerulonephritides (GN): 125 cases (author's transl)].
Berthoux FC; Freyria AM
Nephrologie; 1980; 1(2):61-6. PubMed ID: 7301022
[TBL] [Abstract][Full Text] [Related]
12. The classical complement pathway plays a critical role in the opsonisation of uropathogenic Escherichia coli.
Li K; Sacks SH; Sheerin NS
Mol Immunol; 2008 Feb; 45(4):954-62. PubMed ID: 17870166
[TBL] [Abstract][Full Text] [Related]
13. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation.
Nauta AJ; Trouw LA; Daha MR; Tijsma O; Nieuwland R; Schwaeble WJ; Gingras AR; Mantovani A; Hack EC; Roos A
Eur J Immunol; 2002 Jun; 32(6):1726-36. PubMed ID: 12115656
[TBL] [Abstract][Full Text] [Related]
14. Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction steps.
Ollert MW; Kadlec JV; David K; Petrella EC; Bredehorst R; Vogel CW
J Immunol; 1994 Sep; 153(5):2213-21. PubMed ID: 8051421
[TBL] [Abstract][Full Text] [Related]
15. [Interactions between complement system and bacterial walls].
Colomb MG; Bensa JC; Chesne S; Aubert B
Bull Eur Physiopathol Respir; 1983; 19(2):131-6. PubMed ID: 6871492
[TBL] [Abstract][Full Text] [Related]
16. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
Giclas PC
J Immunol; 1982 Jul; 129(1):168-72. PubMed ID: 6979566
[TBL] [Abstract][Full Text] [Related]
17. Alternative pathway of complement is activated during in vitro ventricular assist.
Chen JC; Huynh TN; Serna DL; Sun CP; Ha H; Steward E; Webster S; Brenner M
J Investig Med; 1999 Nov; 47(9):502-6. PubMed ID: 10572381
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
Sahu A; Kay BK; Lambris JD
J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
[TBL] [Abstract][Full Text] [Related]
19. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
[TBL] [Abstract][Full Text] [Related]
20. The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood.
Brekke OL; Christiansen D; Fure H; Fung M; Mollnes TE
J Leukoc Biol; 2007 Jun; 81(6):1404-13. PubMed ID: 17389579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]